Abstract #1100
The response to chemotherapy of mesothelioma tumours as assessed by dynamic contrast-enhanced MRI: first impressions
Andrew B Gill 1,2 , Andrew N Priest 2 , and Nagmi Qureshi 1
1
Radiology, Papworth Hospital NHS Foundation
Trust, Cambridge, United Kingdom,
2
Medical
Physics, Cambridge University Hospitals, Cambridge,
United Kingdom
Mesothelioma has rarely been the subject of DCE-MRI
investigations. This study applies pharmacokinetic
modeling to DCE-MRI data acquired in patients with
mesothelioma tumours to generate parameters associated
with tumour perfusion (e.g.
K
trans
,
v
p
).
Results from examinations before and after chemotherapy
are reported in this abstract. Initial findings indicate
that changes in
K
trans
may
correlate well with the response to treatment as
evaluated by standard CT RECIST measures. Further
patient numbers are needed to confirm these early
impressions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
